These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1955099)

  • 1. Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring.
    Trovati M; Burzacca S; Mularoni E; Massucco P; Cavalot F; Mattiello L; Anfossi G
    Diabetologia; 1991 Sep; 34(9):662-7. PubMed ID: 1955099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination.
    Guillausseau PJ
    Diabet Med; 1997 Sep; 14(9):798-802. PubMed ID: 9300232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents.
    Trovati M; Burzacca S; Mularoni E; Massucco P; Cavalot F; Mattiello L; Anfossi G
    Diabet Med; 1992 Mar; 9(2):134-7. PubMed ID: 1563247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morning blood glucose determination in the monitoring of metabolic control in type 2 elderly diabetic cases treated by oral hypoglycemic agents].
    Ohba K; Koibuchi H; Matsuura Y; Okazaki K; Ajiro Y; Satoh S; Sasai K; Suzuki T; Nnakano H; Mmetori S
    Nihon Ronen Igakkai Zasshi; 1999 Feb; 36(2):122-7. PubMed ID: 10363530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
    Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
    Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple clinical approach to discriminate between "true" and "pseudo" secondary failure to oral hypoglycaemic agents.
    Scionti L; Misericordia P; Santucci A; Santeusanio F; Brunetti P
    Acta Diabetol; 1992; 29(1):20-4. PubMed ID: 1520901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy.
    Grant PJ; Barlow E; Miles DW
    Diabet Med; 1984 Nov; 1(4):284-6. PubMed ID: 6242818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
    Rachman J; Barrow BA; Levy JC; Turner RC
    Diabetologia; 1997 Feb; 40(2):205-11. PubMed ID: 9049482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative glycaemic control in insulin-treated type 2 diabetes patients undergoing gastric bypass surgery.
    Cruijsen M; Koehestani P; Huttjes S; Leenders K; Janssen I; de Boer H
    Neth J Med; 2014 May; 72(4):202-9. PubMed ID: 24829176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycaemic agents or diet alone. A 3 years epidemiological cohort study on the Island of Falster, Denmark.
    Nielsen NV; Tronier B
    Diabetes Res; 1987 Mar; 4(3):135-9. PubMed ID: 3301161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random blood glucose estimation in type 2 diabetes: does it reflect overall glycaemic control?
    Gill GV; Hardy KJ; Patrick AW; Masterson A
    Diabet Med; 1994; 11(7):705-8. PubMed ID: 7955999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control.
    Schnack C; Bauer I; Pregant P; Hopmeier P; Schernthaner G
    Diabetologia; 1992 Jan; 35(1):77-9. PubMed ID: 1541384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
    Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
    Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.